Last reviewed · How we verify

NCT05034406

The Effect of Subcutaneous and Intraperitoneal Anesthesia on Post Laparoscopic Pain

Completed NA Last updated 5 September 2021
What this trial tests

NA trial testing 2% Lidocaine in Varicocele in 60 participants. Completed in 31 May 2021.

Timeline
1 May 2019
Primary endpoint
31 May 2021
31 May 2021

Quick facts

Lead sponsorKBC Split
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment60
Start date1 May 2019
Primary completion31 May 2021
Estimated completion31 May 2021
Sites1 location across Croatia

Drugs / interventions tested

Conditions studied

Sponsor

KBC Split

Who can join

Adults 12 to 18, any sex, with Varicocele or Postoperative Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Aim of this study is to examine the effects of subcutaneously applied local anesthetics at trocar site in combination with intraoperative intraperitoneal analgesia on duration and character of pain in pediatric patients undergoing laparoscopic varicocelectomy.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The Effect of Subcutaneous and Intraperitoneal Instillation of Local Anesthetics on Postoperative Pain after Laparoscopic Varicocelectomy: A Randomized Controlled Trial.
    Pogorelić Z, Gaberc T, Jukić M, Tintor G, et al · · 2021 · cited 8× · PMID 34828764 · DOI 10.3390/children8111051

Verify or expand the search:

Other trials of 2% Lidocaine

Trials testing the same drug.

Other recruiting trials for Varicocele

Currently open trials in the same condition.

Other KBC Split trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05034406.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing